SMTL ID : 2f7e.1

PKA complexed with (S)-2-(1H-Indol-3-yl)-1-(5-isoquinolin-6-yl-pyridin-3-yloxymethyl-etylamine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 2EA: (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE(Non-covalent)

2EA.1: 18 residues within 4Å: Chain A: L.50, G.51, T.52, G.53, G.56, R.57, V.58, A.71, K.73, M.121, E.122, Y.123, V.124, N.172, L.174, T.184, D.185, F.328 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.50, A:V.58, A:V.58, A:A.71, A:L.174, A:T.184, A:F.328 Hydrogen bonds: A:V.124, A:N.172, A:D.185, A:D.185 Water bridges: A:K.73, A:K.73, A:K.169, A:K.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, Q. et al., Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer. Bioorg.Med.Chem.Lett. (2006)

Release Date

2006-06-27

Peptides

cAMP-dependent protein kinase, alpha-catalytic subunit: A
PKI inhibitory peptide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
I

cAMP-dependent protein kinase, alpha-catalytic subunit

PKI inhibitory peptide

Related Entries With Identical Sequence